The frequency of five clinically relevant alternate transcripts, including androgen receptor variant 7 (ARv7), hepatocyte growth factor receptor exon 14 skip (METe14), and epidermal growth factor receptor variants (EGFRv) vIII/vIVa/vIVb, was determined overall and by cancer type. The gene discussed is MET; the disease is cancer.